文献速递生殖医学

ICSI不增加非男性因素不孕夫妇的累积活产率

ICSI does not increase the cumulative live birth rate in non-male factor infertility.
PubMed 文献 · Hum Reprod · 2018-01-01

基于澳大利亚维多利亚州14 693名首次刺激周期女性的回顾性人群队列,比较IVF与ICSI的累积活产率。ICSI组与IVF组累积活产率相似(37.0% vs 36.0%),调整后风险比0.99(95%CI 0.92-1.06);在非男性因素不孕夫妇中亦相似(AHR 0.96,95%CI 0.85-1.10)。

要点

  • ICSI组与IVF组累积活产率相似(37.0% vs 36.0%),调整后风险比0.99(95%CI 0.92-1.06)。
  • 非男性因素不孕夫妇中,ICSI与IVF累积活产率相似(AHR 0.96,95%CI 0.85-1.10)。
  • ICSI组每取卵周期受精率低于IVF组(56.2% vs 59.8%,P<0.001)。

核心结论

  • ICSI与常规IVF相比累积活产率相似,在非男性因素不孕夫妇中ICSI未显示活产率优势。

研究设计与样本

  • 回顾性人群队列研究,纳入2009年7月至2014年6月在澳大利亚维多利亚州首次刺激周期且至少一枚卵母细胞行IVF或ICSI的14 693名女性。
  • 随访至2016年6月30日、活产或首次取卵所获胚胎用尽,比较首次取卵后的累积活产率。

主要发现

  • IVF组4993名女性行7980次胚胎移植,ICSI组8470名女性行13 092次胚胎移植,分别获得1848例和3046例活产。
  • IVF组与ICSI组分别有19.0%和17.9%的女性在研究期间经历三个或以上周期。
  • 达到活产者中,IVF组与ICSI组从取卵到活产的中位时间均为8.9个月(范围分别为4.2-66.5和4.5-71.3,P=0.474)。
  • 每取卵周期受精率IVF组高于ICSI组(59.8% vs 56.2%,P<0.001)。
  • 总体累积活产率IVF组37.0% vs ICSI组36.0%,ICSI组活产可能性与IVF组无显著差异(AHR 0.99,95%CI 0.92-1.06)。

关键数值与推荐

  • 在已知不孕原因的夫妇中,非男性因素不孕(仅女性因素或不明原因)在IVF组占64.0%,在ICSI组占36.8%(P<0.001)。
  • 非男性因素不孕夫妇中,ICSI与IVF累积活产率相似(AHR 0.96,95%CI 0.85-1.10)。

临床怎么用

  • 作者认为,这些数据提示对于非男性因素不孕夫妇,ICSI在活产率方面较常规IVF无优势。

局限性

  • 缺乏各诊所针对IVF和ICSI的具体方案和流程数据,及其对临床结局的潜在影响。
  • 报告的不孕原因基于治疗临床医生的分类,不同临床医生之间可能存在差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the cumulative live birth rate following ICSI cycles compared with IVF cycles for couples with non-male factor infertility? SUMMARY ANSWER: ICSI resulted in a similar cumulative live birth rate compared with IVF for couples with non-male factor infertility. WHAT IS KNOWN ALREADY: The ICSI procedure was developed for couples with male factor infertility. There has been an increased use of ICSI regardless of the cause of infertility. Cycle-based statistics show that there is no difference in pregnancy rates between ICSI and IVF in couples with non-male factor infertility. However, evidence indicates that ICSI is associated with an increased risk of adverse perinatal outcomes. STUDY DESIGN, SIZE, DURATION: A population-based cohort of 14 693 women, who had their first ever stimulated cycle with fertilization performed for at least one oocyte by either IVF or ICSI between July 2009 and June 2014 in Victoria, Australia was evaluated retrospectively. The pregnancy and birth outcomes following IVF or ICSI were recorded for the first oocyte retrieval (fresh stimulated cycle and associated thaw cycles) until 30 June 2016, or until a live birth was achieved, or until all embryos from the first oocyte retrieval had been used. PARTICIPANTS/MATERIALS, SETTING, METHODS: Demographic, treatment characteristics and resulting outcome data were obtained from the Victorian Assisted Reproductive Treatment Authority. Data items in the VARTA dataset were collected from all fertility clinics in Victoria. Women were grouped by whether they had undergone IVF or ICSI. The primary outcome was the cumulative live birth rate, which was defined as live deliveries (at least one live birth) per woman after the first oocyte retrieval. A discrete-time survival model was used to evaluate the cumulative live birth rate following IVF and ICSI. The adjustment was made for year of treatment in which fertilization occurred, the woman's and male partner's age at first stimulated cycle, parity and the number of oocytes retrieved in the first stimulated cycle. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 4993 women undergoing IVF and 8470 women undergoing ICSI had 7980 and 13 092 embryo transfers, resulting in 1848 and 3046 live deliveries, respectively. About one-fifth of the women (19.0% of the IVF group versus 17.9% of the ICSI group) had three or more cycles during the study period. For couples who achieved a live delivery, the median time from oocyte retrieval to live delivery was 8.9 months in both IVF (range: 4.2-66.5) and ICSI group (range: 4.5-71.3) (P = 0.474). Fertilization rate per oocyte retrieval was higher in the IVF than in the ICSI group (59.8 versus 56.2%, P < 0.001). The overall cumulative live birth rate was 37.0% for IVF and 36.0% for ICSI. The overall likelihood of a live birth for women undergoing ICSI was not significantly different to that for women undergoing IVF (adjusted hazard ratio (AHR): 0.99, 95% CI: 0.92-1.06). For couples with a known cause of infertility, non-male factor infertility (female factor only or unexplained infertility) was reported for 64.0% in the IVF group and 36.8% in the ICSI group (P < 0.001). Among couples with non-male factor infertility, ICSI resulted in a similar cumulative live birth rate compared with IVF (AHR: 0.96, 95% CI: 0.85-1.10). LIMITATIONS, REASONS FOR CAUTION: Data were not available on clinic-specific protocols and processes for IVF and ICSI and the potential impact of these technique aspects on clinical outcomes. The reported causes of infertility were based on the treating clinician's classification which may vary between clinicians. WIDER IMPLICATIONS OF THE FINDINGS: This population-based study found ICSI resulted in a lower fertilization rate per oocyte retrieved and a similar cumulative live birth rate compared to conventional IVF. These data suggest that ICSI offers no advantage over conventional IVF in terms of live birth rate for couples with non-male factor infertility. STUDY FUNDING/COMPETING INTEREST(S): No specific funding was received to undertake this study. There is no conflict of interest, except that M.B. is a shareholder in Genea Ltd. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Li Z, Wang AY, Bowman M, et al. ICSI does not increase the cumulative live birth rate in non-male factor infertility. Hum Reprod. 2018. PMID: 29897449. doi:10.1093/humrep/dey118

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。